SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-16-000055
Filing Date
2016-08-15
Accepted
2016-08-15 16:45:38
Documents
39
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a6301610q.htm 10-Q 664186
2 EXHIBIT 31.1 a63016exhibit311.htm EX-31.1 9300
3 EXHIBIT 31.2 a63016exhibit312.htm EX-31.2 9383
4 EXHIBIT 32.1 a63016exhibit321.htm EX-32.1 5754
5 EXHIBIT 32.2 a63016exhibit322.htm EX-32.2 5816
  Complete submission text file 0001636050-16-000055.txt   1936939

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axon-20160630.xml EX-101.INS 172337
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20160630.xsd EX-101.SCH 19145
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20160630_cal.xml EX-101.CAL 36005
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20160630_def.xml EX-101.DEF 54397
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20160630_lab.xml EX-101.LAB 238005
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20160630_pre.xml EX-101.PRE 125723
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 161833444
SIC: 2834 Pharmaceutical Preparations